Tripod Therapeutics is a biopharmaceutical company that specializes in proteasome dynamics and its manipulation for treating illnesses. It was established on the basis of comprehensive scientific research conducted by Nobel Prize Laureate Prof Aaron Ciechanover and his team. Tripod Therapeutics is developing an orally available drug substance that regulates proteasome localization, thus tricking cancer cells and leading them to their death. The company has already demonstrated the efficacy of its novel approach in several animal models of cancer, and are now working towards the initiation of pre-clinical trials and clinical studies.